title: Selective Spectrofluorimetric Method with Enhanced Sensitivity for Determination of Silodosine in Dosage Form and Human Plasma. Application to Stability Studies and Content Uniformity Testing.
abstract: A novel, sensitive and selective spectrofluorimetric method has been developed and validated for determination of silodosine (SLD) in its dosage form and human plasma. The method is based on nucleophilic substitution reaction of SLD with 5-(dimethylamino) naphthalene-1-sulfonyl chloride (dansyl chloride) in presence of 5.0 × 10-4M sodium carbonate (pH 10.50) to yield a highly fluorescent derivative that was measured at 435 nm after excitation at 347 nm. The different experimental parameters affecting the development and stability of the reaction product were carefully studied and optimized. The fluorescence-concentration plot was rectilinear over the range 30.0-200.0 ng ml-1, with a correlation coefficient of 0.9979. The limits of detection (LOD) and quantification (LOQ) were found to be 5.44 and 16.47 ng ml-1, respectively. The proposed method was validated according to ICH guidelines, and successfully applied to the assay of commercial capsules as well as content uniformity testing. The high sensitivity of the proposed method allowed its successful application to the analysis of SLD in spiked human plasma with % recovery of 92.88 ± 1.05-100.73 ± 0.75%, (n = 6). The application of the proposed method was further extended to stability studies of SLD after exposure to different forced degradation conditions, such as acidic, alkaline and oxidative conditions, according to ICH guidelines, where this work describe the first attempt for selective spectrofluorimetric determination of silodosine in plasma and in the presence of its oxidative degradation.
authors.affiliation: Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt. momar1971g@yahoo.com.
authors.forename: Mahmoud A
authors.initials: MA
authors.lastname: Omar
authors.affiliation: Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
authors.forename: Abdel-Maaboud I
authors.initials: AI
authors.lastname: Mohamed
authors.affiliation: Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
authors.forename: Sayed M
authors.initials: SM
authors.lastname: Derayea
authors.affiliation: Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Hammad
authors.affiliation: Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.
authors.forename: Abobakr A
authors.initials: AA
authors.lastname: Mohamed
mesh_terms: D002214:Capsules / Q000737:chemistry*; D004339:Drug Compounding; D006801:Humans; D007211:Indoles / Q000097:blood* / Q000737:chemistry*; D013050:Spectrometry, Fluorescence / Q000379:methods*; D064804:Urological Agents / Q000097:blood / Q000737:chemistry
chemical_list: D002214:Capsules; D007211:Indoles; D064804:Urological Agents; C095285:silodosin
keywords: Content uniformity; Dansyl chloride; Silodosine; Spiked human plasma